Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Sorafenib 200mg tablets
0801050AJAAAAAA
|
Sorafenib | Sorafenib | Malignant Disease and Immunosuppression | No data available |
|
Sprycel 100mg tablets
0801050ANBBADAD
|
Sprycel | Dasatinib | Malignant Disease and Immunosuppression | No data available |
|
Sprycel 10mg/ml oral suspension
0801050ANBBAGAG
|
Sprycel | Dasatinib | Malignant Disease and Immunosuppression | No data available |
|
Sprycel 140mg tablets
0801050ANBBAEAE
|
Sprycel | Dasatinib | Malignant Disease and Immunosuppression | No data available |
|
Sprycel 20mg tablets
0801050ANBBAAAA
|
Sprycel | Dasatinib | Malignant Disease and Immunosuppression | No data available |
|
Sprycel 50mg tablets
0801050ANBBABAB
|
Sprycel | Dasatinib | Malignant Disease and Immunosuppression | No data available |
|
Sprycel 70mg tablets
0801050ANBBACAC
|
Sprycel | Dasatinib | Malignant Disease and Immunosuppression | No data available |
|
Sprycel 80mg tablets
0801050ANBBAFAF
|
Sprycel | Dasatinib | Malignant Disease and Immunosuppression | No data available |
|
Stivarga 40mg tablets
0801050BNBBAAAA
|
Stivarga | Regorafenib | Malignant Disease and Immunosuppression | No data available |
|
Sunitinib 12.5mg capsules
0801050AMAAAAAA
|
Sunitinib | Sunitinib | Malignant Disease and Immunosuppression | No data available |
|
Sunitinib 25mg capsules
0801050AMAAABAB
|
Sunitinib | Sunitinib | Malignant Disease and Immunosuppression | No data available |
|
Sunitinib 37.5mg capsules
0801050AMAAADAD
|
Sunitinib | Sunitinib | Malignant Disease and Immunosuppression | No data available |
|
Sunitinib 50mg capsules
0801050AMAAACAC
|
Sunitinib | Sunitinib | Malignant Disease and Immunosuppression | No data available |
|
Sutent 12.5mg capsules
0801050AMBBAAAA
|
Sutent | Sunitinib | Malignant Disease and Immunosuppression | No data available |
|
Sutent 25mg capsules
0801050AMBBABAB
|
Sutent | Sunitinib | Malignant Disease and Immunosuppression | No data available |
|
Sutent 50mg capsules
0801050AMBBACAC
|
Sutent | Sunitinib | Malignant Disease and Immunosuppression | No data available |
|
Sylvant 100mg pdr for concentrate for inf vials
0802040AMBBABAB
|
Sylvant | Siltuximab | Malignant Disease and Immunosuppression | No data available |
|
Sylvant 400mg pdr for concentrate for inf vials
0802040AMBBAAAA
|
Sylvant | Siltuximab | Malignant Disease and Immunosuppression | No data available |
|
Tacni 0.5mg capsules
0802020T0BGAAAF
|
Tacni | Tacrolimus | Malignant Disease and Immunosuppression | No data available |
|
Tacni 1mg capsules
0802020T0BGABAB
|
Tacni | Tacrolimus | Malignant Disease and Immunosuppression | No data available |
|
Tacni 5mg capsules
0802020T0BGACAA
|
Tacni | Tacrolimus | Malignant Disease and Immunosuppression | No data available |
|
Tacrolimus 0.0001% mouthwash
0802020T0AAAXAX
|
Tacrolimus (Systemic) | Tacrolimus | Malignant Disease and Immunosuppression | No data available |
|
Tacrolimus 25mg/5ml oral liquid
0802020T0AAASAS
|
Tacrolimus (Systemic) | Tacrolimus | Malignant Disease and Immunosuppression | No data available |
|
Tacrolimus 2mg suppositories
0802020T0AABIBI
|
Tacrolimus (Systemic) | Tacrolimus | Malignant Disease and Immunosuppression | No data available |
|
Tacrolimus 2mg/5ml oral suspension
0802020T0AAAKAK
|
Tacrolimus (Systemic) | Tacrolimus | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.